KERALA AYURVEDA
Back to Income Statement
|
KERALA AYURVEDA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹120 Cr | ₹108 Cr | ₹93 Cr | ₹80 Cr | ₹62 Cr |
What is the latest Revenue of KERALA AYURVEDA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹120 Cr |
| Mar2024 | ₹108 Cr |
| Mar2023 | ₹93 Cr |
| Mar2022 | ₹80 Cr |
| Mar2021 | ₹62 Cr |
How is Revenue of KERALA AYURVEDA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹120 Cr | 11.57 | |
| Mar2024 | ₹108 Cr | 15.46 | |
| Mar2023 | ₹93 Cr | 16.25 | |
| Mar2022 | ₹80 Cr | 29.45 | |
| Mar2021 | ₹62 Cr | - | |
Compare Revenue of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹319.0 Cr | 3% | 42.7% | -28.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | 3% |
42.7% |
-28.7% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses